Skip to main content
OpenTrials
Completed

NCT Number: NCT02853877

Helping Employees Lose Pounds

This study will evaluate the effectiveness of financial incentives and messaging tailored to individual goals and aspirations to promote and sustain weight loss. This is a 2-arm randomized controlled trial that will recruit eligible employees at a large university to participate in a 3-month weight loss program, followed by a 3-month follow-up period. The primary outcome will be change in autonomous motivation for weight loss.

The study hypothesis is that intervention group participants will have a greater increase in autonomous motivation for weight loss than participants in the control group at 12 weeks.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Michigan

Ann Arbor, Michigan, 48109, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Interested in losing weight
  • Body Mass Index between 30 and 40 kg/m2
  • Have wireless internet at home
  • Have Android or iOS smart device
  • Willing to record themselves weighing in on a scale or let a family member record them weighing in on a scale

Exclusion criteria

  • Pregnant or lactating, or intending to become pregnant in the next 6 months
  • Taking medication (other than metformin) for diabetes to control blood sugar
  • Having a serious psychiatric diagnosis, unstable medical conditions or experienced a heart attack or stroke in the past 6 months
  • Having a history of drug or alcohol abuse or addiction to prescription medications

Treatment and study plan

Weekly Incentive

Behavioral

The tailored incentives intervention aims to assess the impact of tailored messaging and financial incentives on weight loss among obese employees.

Primary outcomes

  1. Change in autonomous motivation as measured by the Treatment Self-Regulation Questionnaire

    Time frame: 12 weeks

Secondary outcomes

  1. Change in weight as measured by participant weight measurements using Withings scales

    Time frame: 12 weeks and 24 weeks

Other outcomes

  1. Change in autonomous motivation as measured by the Treatment Self-Regulation Questionnaire

    Time frame: 24 weeks

  2. Change in physical activity as measured by the short form of the International Physical Activity Questionnaire

    Time frame: 12 weeks and 24 weeks

  3. Change in eating behaviors as measured by the Three Factor Eating Questionnaire

    Time frame: 12 weeks and 24 weeks

  4. Change in participation in weight-related wellness programs as measured by responses to the question "In the past 3 months, have you participated in any health and wellness programs?"

    Time frame: 12 weeks and 24 weeks

  5. Change in self-efficacy to lose weight as measured by the Perceived Competence Scale

    Time frame: 12 weeks and 24 weeks

  6. Change in stage of change for weight loss as measured by responses to the questions "Are you currently trying to lose weight?" and "Do you intend to try to lose weight in the near future?"

    Time frame: 12 and 24 weeks

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Registry information

Official study title

Translating Insights From Behavioral Economics and Self-Determination Theory to Promote Sustained Weight Loss Among Obese Employees

Acronym: HELP

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Aug 3, 2016
Registry last updated
Apr 18, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.